Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease that affects an individual's
ability to breathe. Currently, no medications can reverse the damage to the lungs caused by
IPF, but individuals are encouraged to engage in moderate exercise to strengthen lung
function. This study will evaluate the effectiveness of sildenafil at improving exercise
tolerance and breathing difficulties in individuals with IPF.